CHEBI:15864 - luteolin

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name luteolin
ChEBI ID CHEBI:15864
Definition A tetrahydroxyflavone in which the four hydroxy groups are located at positions 3', 4', 5 and 7. It is thought to play an important role in the human body as an antioxidant, a free radical scavenger, an anti-inflammatory agent and an immune system modulator as well as being active against several cancers.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:12082, CHEBI:14536, CHEBI:6578, CHEBI:25086
Supplier Information ChemicalBook:CB72747669, ChemicalBook:CB7282616, ChemicalBook:CB71453798, eMolecules:524934, Selleckchem:Luteolin(Luteolol), ZINC000018185774
Download Molfile XML SDF
more structures >>
Wikipedia License
Luteolin is a flavone, a type of flavonoid, with a yellow crystalline appearance. Luteolin is the main yellow dye from the Reseda luteola plant, used for dyeing since at least the first millennium B.C. Luteolin was first isolated in pure form, and named, in 1829 by the French chemist Michel Eugène Chevreul. The luteolin empirical formula was determined by the Austrian chemists Heinrich Hlasiwetz and Leopold Pfaundler in 1864. In 1896, the English chemist Arthur George Perkin proposed the correct structure for luteolin. Perkin's proposed structure for luteolin was confirmed in 1900 when the Polish-Swiss chemist Stanislaw Kostanecki (1860–1910) and his students A. Różycki and J. Tambor synthesized luteolin.
Read full article at Wikipedia
Formula C15H10O6
Net Charge 0
Average Mass 286.239
Monoisotopic Mass 286.04774
InChI InChI=1S/C15H10O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-6,16-19H
InChIKey IQPNAANSBPBGFQ-UHFFFAOYSA-N
SMILES OC1=CC(O)=C2C(=O)C=C(OC2=C1)C1=CC=C(O)C(O)=C1
Metabolite of Species Details
Arabidopsis thaliana (NCBI:txid3702) Found in cell suspension culture (BTO:0000221). From MetaboLights See: MetaboLights Study
Arabidopsis thaliana (NCBI:txid3702) From MetaboLights See: MetaboLights Study
Brassica napus (NCBI:txid3708) Found in leaf lamina (BTO:0000719). From MetaboLights See: MetaboLights Study
Brassica napus (NCBI:txid3708) From MetaboLights See: MetaboLights Study
Brassica napus (NCBI:txid3708) From MetaboLights See: MetaboLights Study
Olea europaea (NCBI:txid4146) Found in leaf (BTO:0000713). Methanolic extract of dried olive leaves See: PubMed
Sorghum bicolor (NCBI:txid4558) From MetaboLights See: MetaboLights Study
Mimosa diplotricha (NCBI:txid512270) Found in aerial part (BTO:0001658). Ethanolic extract of aerial part See: PubMed
Cirsium japonicum (NCBI:txid516546) Found in whole plant (BTO:0001461). Hot methanolic extract of dried whole plant See: PubMed
Lepisorus ussuriensis (NCBI:txid699700) Found in whole plant (BTO:0001461). See: PubMed
Roles Classification
Chemical Role(s): radical scavenger
A role played by a substance that can react readily with, and thereby eliminate, radicals.
Biological Role(s): vascular endothelial growth factor receptor antagonist
An antagonist at the vascular endothelial growth factor receptor.
plant metabolite
Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
c-Jun N-terminal kinase inhibitor
An EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor that inhibits the action of c-Jun N-terminal kinase.
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
EC 2.3.1.85 (fatty acid synthase) inhibitor
An EC 2.3.1.* (acyltransferase transferring other than amino-acyl group) inhibitor that interferes with the action of fatty acid synthase (EC 2.3.1.85), a multi-enzyme protein involved in fatty acid synthesis.
immunomodulator
Biologically active substance whose activity affects or plays a role in the functioning of the immune system.
Application(s): nephroprotective agent
Any protective agent that is able to prevent damage to the kidney.
angiogenesis inhibitor
An agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
anti-inflammatory agent
Any compound that has anti-inflammatory effects.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
immunomodulator
Biologically active substance whose activity affects or plays a role in the functioning of the immune system.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing luteolin (CHEBI:15864) has role angiogenesis inhibitor (CHEBI:48422)
luteolin (CHEBI:15864) has role anti-inflammatory agent (CHEBI:67079)
luteolin (CHEBI:15864) has role antineoplastic agent (CHEBI:35610)
luteolin (CHEBI:15864) has role apoptosis inducer (CHEBI:68495)
luteolin (CHEBI:15864) has role c-Jun N-terminal kinase inhibitor (CHEBI:90172)
luteolin (CHEBI:15864) has role EC 2.3.1.85 (fatty acid synthase) inhibitor (CHEBI:71476)
luteolin (CHEBI:15864) has role immunomodulator (CHEBI:50846)
luteolin (CHEBI:15864) has role nephroprotective agent (CHEBI:76595)
luteolin (CHEBI:15864) has role plant metabolite (CHEBI:76924)
luteolin (CHEBI:15864) has role radical scavenger (CHEBI:48578)
luteolin (CHEBI:15864) has role vascular endothelial growth factor receptor antagonist (CHEBI:65207)
luteolin (CHEBI:15864) is a 3'-hydroxyflavonoid (CHEBI:27741)
luteolin (CHEBI:15864) is a tetrahydroxyflavone (CHEBI:38684)
luteolin (CHEBI:15864) is conjugate acid of luteolin-7-olate (CHEBI:57545)
Incoming 4',5,7-trihydroxy-3'-methoxyflavone (CHEBI:16514) has functional parent luteolin (CHEBI:15864)
5,3'-di-O-methylluteolin (CHEBI:69455) has functional parent luteolin (CHEBI:15864)
6-C-α-L-arabinopyranosyl-8-C-β-D-glucosylluteolin (CHEBI:75566) has functional parent luteolin (CHEBI:15864)
6-C-[2'-O-α-L-rhamnopyranosyl-(1''→2')]-α-L-arabinopyranosylluteolin (CHEBI:70201) has functional parent luteolin (CHEBI:15864)
6-C-[2-O-α-L-rhamnopyranosyl-(1''→2')]-β-D-xylopyranosylluteolin (CHEBI:70202) has functional parent luteolin (CHEBI:15864)
6-hydroxyluteolin (CHEBI:2197) has functional parent luteolin (CHEBI:15864)
6-hydroxyluteolin 7-O-laminaribioside (CHEBI:66046) has functional parent luteolin (CHEBI:15864)
6-methoxyluteolin 7-α-L-rhamnoside (CHEBI:28314) has functional parent luteolin (CHEBI:15864)
7-O-[β-D-arabinopyranosyl-(1→6)-β-D-glucosyl]luteolin (CHEBI:75532) has functional parent luteolin (CHEBI:15864)
carlinoside (CHEBI:3421) has functional parent luteolin (CHEBI:15864)
cassiaoccidentalin B (CHEBI:70205) has functional parent luteolin (CHEBI:15864)
diosmetin (CHEBI:4630) has functional parent luteolin (CHEBI:15864)
hypolaetin (CHEBI:5837) has functional parent luteolin (CHEBI:15864)
isoorientin (CHEBI:17965) has functional parent luteolin (CHEBI:15864)
lucenin-2 (CHEBI:6553) has functional parent luteolin (CHEBI:15864)
luteolin 6-C-[β-D-glucosyl-(1→2)-α-L-arabinoside] (CHEBI:131834) has functional parent luteolin (CHEBI:15864)
luteolin 7-O-β-D-glucoside (CHEBI:27994) has functional parent luteolin (CHEBI:15864)
luteolin 7-O-(6-O-malonyl-β-D-glucoside) (CHEBI:6579) has functional parent luteolin (CHEBI:15864)
luteolin 7-O-neohesperidoside (CHEBI:31788) has functional parent luteolin (CHEBI:15864)
luteolin O-glucuronoside (CHEBI:25091) has functional parent luteolin (CHEBI:15864)
luteolin-4'-O-β-D-glucopyranoside (CHEBI:68986) has functional parent luteolin (CHEBI:15864)
luteolin-7-O-α-L-rhamnoside (CHEBI:70030) has functional parent luteolin (CHEBI:15864)
maysin (CHEBI:70206) has functional parent luteolin (CHEBI:15864)
ochnaflavone (CHEBI:194126) has functional parent luteolin (CHEBI:15864)
orientin (CHEBI:7781) has functional parent luteolin (CHEBI:15864)
luteolin-7-olate (CHEBI:57545) is conjugate base of luteolin (CHEBI:15864)
IUPAC Name
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one
Synonyms Sources
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone ChemIDplus
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one ChemIDplus
3',4',5,7-Tetrahydroxyflavone KEGG COMPOUND
5,7,3',4'-Tetrahydroxyflavone KEGG COMPOUND
digitoflavone ChEBI
flacitran ChEBI
Luteolin KEGG COMPOUND
Luteolol ChemIDplus
Salifazide ChemIDplus
Manual Xrefs Databases
4444102 ChemSpider
5734-TETRAHYDROXYFLAVONE MetaCyc
C00000674 KNApSAcK
C01514 KEGG COMPOUND
DB15584 DrugBank
FDB013255 FooDB
HMDB0005800 HMDB
LMPK12110006 LIPID MAPS
LSM-5229 LINCS
LU2 PDBeChem
Luteolin Wikipedia
View more database links
Registry Numbers Types Sources
292084 Reaxys Registry Number Reaxys
491-70-3 CAS Registry Number ChemIDplus
491-70-3 CAS Registry Number NIST Chemistry WebBook
Citations
Zima V, Radilová K, Kožíšek M, Albiñana CB, Karlukova E, Brynda J, Fanfrlík J, Flieger M, Hodek J, Weber J, Majer P, Konvalinka J, Machara A (2020)
Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
European journal of medicinal chemistry 208, 112754 [PubMed:32883638]
[show Abstract]
Gu C, Stashko MA, Puhl-Rubio AC, Chakraborty M, Chakraborty A, Frye SV, Pearce KH, Wang X, Shears SB, Wang H (2019)
Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis.
Journal of medicinal chemistry 62, 1443-1454 [PubMed:30624931]
[show Abstract]
Fan S, Habib A, Liu J, Tan J (2018)
LED enhances anti-inflammatory effect of luteolin (3',4',5,7-tetrahydroxyflavone) in vitro.
American journal of translational research 10, 283-291 [PubMed:29423013]
[show Abstract]
Qing W, Wang Y, Li H, Ma F, Zhu J, Liu X (2017)
Preparation and Characterization of Copolymer Micelles for the Solubilization and In Vitro Release of Luteolin and Luteoloside.
AAPS PharmSciTech 18, 2095-2101 [PubMed:28004344]
[show Abstract]
Palko-Labuz A, Sroda-Pomianek K, Uryga A, Kostrzewa-Suslow E, Michalak K (2017)
Anticancer activity of baicalein and luteolin studied in colorectal adenocarcinoma LoVo cells and in drug-resistant LoVo/Dx cells.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 88, 232-241 [PubMed:28110189]
[show Abstract]
Cook MT, Liang Y, Besch-Williford C, Hyder SM (2017)
Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells.
Breast cancer (Dove Medical Press) 9, 9-19 [PubMed:28096694]
[show Abstract]
Wang L, Chen Q, Zhu L, Li Q, Zeng X, Lu L, Hu M, Wang X, Liu Z (2017)
Metabolic Disposition of Luteolin Is Mediated by the Interplay of UDP-Glucuronosyltransferases and Catechol-O-Methyltransferases in Rats.
Drug metabolism and disposition: the biological fate of chemicals 45, 306-315 [PubMed:28031430]
[show Abstract]
Nunes C, Almeida L, Barbosa RM, Laranjinha J (2017)
Luteolin suppresses the JAK/STAT pathway in a cellular model of intestinal inflammation.
Food & function 8, 387-396 [PubMed:28067377]
[show Abstract]
Zhang L, Zhao X, Tao GJ, Chen J, Zheng ZP (2017)
Investigating the inhibitory activity and mechanism differences between norartocarpetin and luteolin for tyrosinase: A combinatory kinetic study and computational simulation analysis.
Food chemistry 223, 40-48 [PubMed:28069121]
[show Abstract]
Xiong J, Wang K, Yuan C, Xing R, Ni J, Hu G, Chen F, Wang X (2017)
Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects.
International journal of molecular medicine 39, 113-125 [PubMed:27878246]
[show Abstract]
Gao D, Wang DD, Zhang Q, Yang FQ, Xia ZN, Zhang QH, Yuan CS (2017)
In Vivo Selective Capture and Rapid Identification of Luteolin and Its Metabolites in Rat Livers by Molecularly Imprinted Solid-Phase Microextraction.
Journal of agricultural and food chemistry 65, 1158-1166 [PubMed:28111945]
[show Abstract]
Ha SK, Lee JA, Cho EJ, Choi I (2017)
Effects of Catechol O-Methyl Transferase Inhibition on Anti-Inflammatory Activity of Luteolin Metabolites.
Journal of food science 82, 545-552 [PubMed:28071803]
[show Abstract]
Keller AN, Eckle SB, Xu W, Liu L, Hughes VA, Mak JY, Meehan BS, Pediongco T, Birkinshaw RW, Chen Z, Wang H, D'Souza C, Kjer-Nielsen L, Gherardin NA, Godfrey DI, Kostenko L, Corbett AJ, Purcell AW, Fairlie DP, McCluskey J, Rossjohn J (2017)
Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.
Nature immunology 18, 402-411 [PubMed:28166217]
[show Abstract]
Lin D, Kuang G, Wan J, Zhang X, Li H, Gong X, Li H (2017)
Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
Oncology reports 37, 895-902 [PubMed:27959422]
[show Abstract]
Lee YJ, Lim T, Han MS, Lee SH, Baek SH, Nan HY, Lee C (2017)
Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells.
Oncology reports 37, 1219-1226 [PubMed:28035396]
[show Abstract]
Tambe R, Patil A, Jain P, Sancheti J, Somani G, Sathaye S (2017)
Assessment of luteolin isolated from Eclipta alba leaves in animal models of epilepsy.
Pharmaceutical biology 55, 264-268 [PubMed:27927066]
[show Abstract]
Hu W, Xu T, Wu P, Pan D, Chen J, Chen J, Zhang B, Zhu H, Li D (2017)
Luteolin improves cardiac dysfunction in heart failure rats by regulating sarcoplasmic reticulum Ca2+-ATPase 2a.
Scientific reports 7, 41017 [PubMed:28112209]
[show Abstract]
Hytti M, Szabó D, Piippo N, Korhonen E, Honkakoski P, Kaarniranta K, Petrovski G, Kauppinen A (2017)
Two dietary polyphenols, fisetin and luteolin, reduce inflammation but augment DNA damage-induced toxicity in human RPE cells.
The Journal of nutritional biochemistry 42, 37-42 [PubMed:28113103]
[show Abstract]
Pan D, Li D (2016)
At the crossroads from bench to bedside: luteolin is a promising pharmacological agent against myocardial ischemia reperfusion injury.
Annals of translational medicine 4, 475 [PubMed:28090531]
Tsai PH, Cheng CH, Lin CY, Huang YT, Lee LT, Kandaswami CC, Lin YC, Lee KP, Hung CC, Hwang JJ, Ke FC, Chang GD, Lee MT (2016)
Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells.
Anticancer research 36, 6367-6380 [PubMed:27919958]
[show Abstract]
Xia N, Chen G, Liu M, Ye X, Pan Y, Ge J, Mao Y, Wang H, Wang J, Xie S (2016)
Anti-inflammatory effects of luteolin on experimental autoimmune thyroiditis in mice.
Experimental and therapeutic medicine 12, 4049-4054 [PubMed:28101184]
[show Abstract]
Usman Amin M, Khurram M, Khan TA, Faidah HS, Ullah Shah Z, Ur Rahman S, Haseeb A, Ilyas M, Ullah N, Umar Khayam SM, Iriti M (2016)
Effects of Luteolin and Quercetin in Combination with Some Conventional Antibiotics against Methicillin-Resistant Staphylococcus aureus.
International journal of molecular sciences 17, E1947 [PubMed:27879665]
[show Abstract]
Xin SB, Yan H, Ma J, Sun Q, Shen L (2016)
Protective Effects of Luteolin on Lipopolysaccharide-Induced Acute Renal Injury in Mice.
Medical science monitor : international medical journal of experimental and clinical research 22, 5173-5180 [PubMed:28029146]
[show Abstract]
Hwang SH, Paek JH, Lim SS (2016)
Simultaneous Ultra Performance Liquid Chromatography Determination and Antioxidant Activity of Linarin, Luteolin, Chlorogenic Acid and Apigenin in Different Parts of Compositae Species.
Molecules (Basel, Switzerland) 21, E1609 [PubMed:27886116]
[show Abstract]
Zhang Q, Yang J, Wang J (2016)
Modulatory effect of luteolin on redox homeostasis and inflammatory cytokines in a mouse model of liver cancer.
Oncology letters 12, 4767-4772 [PubMed:28101223]
[show Abstract]
Arslan BY, Arslan F, Erkalp K, Alagöl A, Sevdi MS, Yıldız G, Küçük SH, Altınay S (2016)
Luteolin ameliorates colistin-induced nephrotoxicity in the rat models.
Renal failure 38, 1735-1740 [PubMed:27764981]
[show Abstract]
Shen ML, Wang CH, Lin CH, Zhou N, Kao ST, Wu DC (2016)
Luteolin Attenuates Airway Mucus Overproduction via Inhibition of the GABAergic System.
Scientific reports 6, 32756 [PubMed:27595800]
[show Abstract]
Yang D, Tan X, Lv Z, Liu B, Baiyun R, Lu J, Zhang Z (2016)
Regulation of Sirt1/Nrf2/TNF-α signaling pathway by luteolin is critical to attenuate acute mercuric chloride exposure induced hepatotoxicity.
Scientific reports 6, 37157 [PubMed:27853236]
[show Abstract]
Yokoyama T, Kosaka Y, Mizuguchi M (2015)
Structural Insight into the Interactions between Death-Associated Protein Kinase 1 and Natural Flavonoids.
Journal of medicinal chemistry 58, 7400-7408 [PubMed:26322379]
[show Abstract]
Iakovleva I, Begum A, Pokrzywa M, Walfridsson M, Sauer-Eriksson AE, Olofsson A (2015)
The flavonoid luteolin, but not luteolin-7-O-glucoside, prevents a transthyretin mediated toxic response.
PloS one 10, e0128222 [PubMed:26020516]
[show Abstract]
Narwal M, Haikarainen T, Fallarero A, Vuorela PM, Lehtiö L (2013)
Screening and structural analysis of flavones inhibiting tankyrases.
Journal of medicinal chemistry 56, 3507-3517 [PubMed:23574272]
[show Abstract]
Jeon YW, Suh YJ (2013)
Synergistic apoptotic effect of celecoxib and luteolin on breast cancer cells.
Oncology reports 29, 819-825 [PubMed:23229294]
[show Abstract]
Guo DJ, Li F, Yu PH, Chan SW (2013)
Neuroprotective effects of luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma PC12 cells.
Pharmaceutical biology 51, 190-196 [PubMed:23035972]
[show Abstract]
Androutsopoulos VP, Spandidos DA (2013)
The flavonoids diosmetin and luteolin exert synergistic cytostatic effects in human hepatoma HepG2 cells via CYP1A-catalyzed metabolism, activation of JNK and ERK and P53/P21 up-regulation.
The Journal of nutritional biochemistry 24, 496-504 [PubMed:22749133]
[show Abstract]
Lolli G, Cozza G, Mazzorana M, Tibaldi E, Cesaro L, Donella-Deana A, Meggio F, Venerando A, Franchin C, Sarno S, Battistutta R, Pinna LA (2012)
Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight.
Biochemistry 51, 6097-6107 [PubMed:22794353]
[show Abstract]
Trivella DB, dos Reis CV, Lima LM, Foguel D, Polikarpov I (2012)
Flavonoid interactions with human transthyretin: combined structural and thermodynamic analysis.
Journal of structural biology 180, 143-153 [PubMed:22842046]
[show Abstract]
Puhl AC, Bernardes A, Silveira RL, Yuan J, Campos JL, Saidemberg DM, Palma MS, Cvoro A, Ayers SD, Webb P, Reinach PS, Skaf MS, Polikarpov I (2012)
Mode of peroxisome proliferator-activated receptor γ activation by luteolin.
Molecular pharmacology 81, 788-799 [PubMed:22391103]
[show Abstract]
Lee WC, Jung HA, Choi JS, Kim YS, Lee SM (2011)
Protective effects of luteolin against apoptotic liver damage induced by D-galactosamine/lipopolysaccharide in mice.
Journal of natural products 74, 1916-1921 [PubMed:21899269]
[show Abstract]
Raines T, Jones P, Moe N, Duncan R, McCall S, Ceremuga TE (2009)
Investigation of the anxiolytic effects of luteolin, a lemon balm flavonoid in the male Sprague-Dawley rat.
AANA journal 77, 33-36 [PubMed:19263826]
[show Abstract]
Ando C, Takahashi N, Takahashi N, Hirai S, Nishimura K, Lin S, Uemura T, Goto T, Yu R, Nakagami J, Murakami S, Kawada T (2009)
Luteolin, a food-derived flavonoid, suppresses adipocyte-dependent activation of macrophages by inhibiting JNK activation.
FEBS letters 583, 3649-3654 [PubMed:19854181]
[show Abstract]
Zhou Q, Yan B, Hu X, Li XB, Zhang J, Fang J (2009)
Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin.
Molecular cancer therapeutics 8, 1684-1691 [PubMed:19509250]
[show Abstract]
Lin Y, Shi R, Wang X, Shen HM (2008)
Luteolin, a flavonoid with potential for cancer prevention and therapy.
Current cancer drug targets 8, 634-646 [PubMed:18991571]
[show Abstract]
Kaneko M, Takimoto H, Sugiyama T, Seki Y, Kawaguchi K, Kumazawa Y (2008)
Suppressive effects of the flavonoids quercetin and luteolin on the accumulation of lipid rafts after signal transduction via receptors.
Immunopharmacology and immunotoxicology 30, 867-882 [PubMed:18720166]
[show Abstract]
Seelinger G, Merfort I, Wölfle U, Schempp CM (2008)
Anti-carcinogenic effects of the flavonoid luteolin.
Molecules (Basel, Switzerland) 13, 2628-2651 [PubMed:18946424]
[show Abstract]
Lee S, Seo DH, Park HL, Choi Y, Jung S (2003)
Solubility enhancement of a hydrophobic flavonoid, luteolin by the complexation with cyclosophoraoses isolated from Rhizobium meliloti.
Antonie van Leeuwenhoek 84, 201-207 [PubMed:14574115]
[show Abstract]
Kotanidou A, Xagorari A, Bagli E, Kitsanta P, Fotsis T, Papapetropoulos A, Roussos C (2002)
Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice.
American journal of respiratory and critical care medicine 165, 818-823 [PubMed:11897650]
[show Abstract]
Romanová D, Vachálková A, Cipák L, Ovesná Z, Rauko P (2001)
Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method.
Neoplasma 48, 104-107 [PubMed:11478688]
[show Abstract]
Last Modified
23 December 2022